Published in Women's Health Weekly, August 10th, 2006
"In a range of human cancers, tumorigenesis is promoted by activation of the endothelin A receptor (ETAR)/ET-1 axis. ET-1 and ETAR are overexpressed in primary and metastatic ovarian carcinomas, and high levels of ET-1 are detectable in patient ascites, suggesting that ET-1 may promote tumor dissemination," scientists in Italy report.
"Moreover, in these tumors, engagement of ETA receptor by ET-1 triggers tumor growth, survival, angiogenesis, and invasiveness. Thus, ET-1 enhances the secretion of matrix metalloproteinases, disrupts intercellular communications, and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly